🔗 Share this article

Treasury head Reeves has revealed she is preparing "focused action to tackle cost of living challenges" in the upcoming financial statement.

In comments to media outlets, she noted that lowering inflation is a joint duty of both the government and the Bank of England.

The United Kingdom's inflation rate is projected to be the highest among the G7 advanced economies this year and the following year.

Possible Energy Cost Measures

Reports indicate the government could take action to bring down energy bills, for instance by slashing the present 5% rate of VAT applied on energy.

Another possibility is to lower some of the regulatory levies presently included in bills.

Fiscal Constraints and Analyst Predictions

The administration will obtain the latest draft from the official forecaster, the OBR, on Monday, which will reveal how much scope there is for such actions.

The consensus from the majority of analysts is that Reeves will have to introduce tax rises or expenditure reductions in order to fulfill her self-imposed debt limits.

Previously on the same day, analysis suggested there was a £22 billion deficit for the chancellor to address, which is at the more modest range of forecasts.

"It is a shared responsibility between the Bank of England and the administration to continue tackling some of the sources of price increases," Reeves told the BBC in the US capital, at the yearly gatherings of the IMF and World Bank.

Revenue Pledges and Global Concerns

While a great deal of the attention has been on likely tax increases, the chancellor said the latest information from the fiscal watchdog had not changed her pledge to manifesto promises not to raise tax levels on earnings tax, sales tax or social security contributions.

She blamed an "uncertain world" with increasing geopolitical and commercial concerns for the Budget revenue measures, likely to be targeted on those "most able to pay."

International Economic Tensions

Commenting on apprehensions about the United Kingdom's commercial links with China she said: "The UK's security interests invariably come first."

Recent statement by Chinese authorities to tighten trade restrictions on critical minerals and other materials that are key for advanced tech manufacturing led US President Donald Trump to suggest an extra 100% import tax on imports from China, raising the prospect of an all-out commercial conflict between the two economic giants.

The US Treasury Secretary described the Chinese move "commercial pressure" and "a global supply chain control attempt."

Asked about accepting the American proposal to join its conflict with the Asian nation, Reeves said she was "very concerned" by China's actions and urged the Chinese government "not to put up barriers and limit trade."

She said the move was "harmful for the world economy and generates additional headwinds."

"I believe there are areas where we should confront China, but there are also important chances to trade with China's economy, including financial services and other sectors of the economy. We've got to maintain that equilibrium correct."

The chancellor also affirmed she was cooperating with international partners "on our own critical minerals approach, so that we are reduced dependence."

Health Service Drug Pricing and Investment

Reeves also admitted that the cost the NHS spends on medicines could rise as a result of ongoing talks with the US government and its drugs companies, in return for reduced taxes and funding.

Some of the biggest global pharmaceutical manufacturers have said lately that they are either delaying or canceling projects in the United Kingdom, with some blaming the modest returns they are receiving.

Last month, the government science advisor said the cost the NHS spends on medicines would need to rise to stop companies and drug research funding leaving the United Kingdom.

The Chancellor told the BBC: "We have seen because of the pricing regime, that drug testing, new drugs have not been available in the UK in the way that they are in other European countries."

"Our aim is to make sure that people receiving treatment from the NHS are can obtain the finest life-saving medicines in the world. And so we are examining all of that, and... seeking to attract additional investment into the UK."